baber/WOPTO huggingface dataset:
Patent AU-783280-B2 (AU)
Title: Method for producing L-glutamic acid
Inventor: SATO MASAKAZU
IPC: C12R1/01
Filed: 2002-02-19
Granted: 2005-10-06
Abstract: A method for producing L-glutamic acid by fermentation, which comprises culturing a microorganism having L-glutamic acid-producing ability in a medium having pH of 5.0 or less, wherein a total content of an organic acid that inhibits growth of the microorganism at the pH is one at which the growth of the microorganism is not inhibited; and a method for producing L-glutamic acid by fermentation, which comprises culturing a microorganism having L-glutamic acid-producing ability at a first pH at which growth of the microorganism is not inhibited by an organic acid in a medium, and then culturing the microorganism at a second pH that is suitable for L-glutamic acid production by the microorganism and is lower than the first pH.
Patent AU-710656-B2 (AU)
Title: Address generating apparatus, picture display apparatus, address generating method and picture displaying method
Inventor: OHBA AKIO
IPC: G09G5/39
Filed: 1997-02-06
Granted: 1999-09-23
Abstract: Picture data read out from a VRAM 18 are sent via line buffers 75a to 75d to a selection synthesis unit 63. The line buffer 75d seizes picture data supplied from outside for sending the seized picture data to the VRAM 18. The VRAM 18 can write the picture data from outside supplied via the line buffer 75d and read out the picture data based on addresses from a controller in the same way as other picture data. On the other hand, cache memories 74a and 74b can read out picture data under control by the controller 71 to display plural pictures in a tiled pattern on a display screen. <IMAGE>
Patent AU-660028-B2 (AU)
Title: Praseodymium-palladium binary oxide, catalyst compositions
Inventor: CHOU TING C
IPC: B01J23/96
Filed: 1992-03-20
Granted: 1995-06-08
Abstract: A catalyst composition containing one or more binary oxides of palladium and rare earth metal such as Ce, La, Nd, Pr and/or Sm. The catalyst composition is used for the catalytic combustion of gaseous combustion mixtures of oxygen and carbonaceous fuels such as methane, e.g., a natural gas/air combustion mixture. Specific preferred binary oxides may be, for example, M2O3.PdO (e.g., La2O3.PdO) or 2M2O3.PdO, wherein in each case M is La, Nd or Sm. A process of combusting gaseous carbonaceous fuels includes contacting a catalyst as described above under combustion conditions, e.g., 925 DEG  C. to 1650 DEG  C. and 1 to 20 atmospheres pressure, to carry out sustained combustion of the combustion mixture, including catalytically supported thermal combustion. Regeneration of over-temperatured M2O3.PdO catalyst is also provided for.
Patent AU-674126-B2 (AU)
Title: Tissue treatment composition comprising fibrin or fibrinogenand biodegradable and biocompatible polymer
Inventor: WADSTROM JONAS
IPC: A61F2/28
Filed: 1992-06-17
Granted: 1996-12-12
Abstract: PCT No. PCT/SE92/00441 Sec. 371 Date Feb. 7, 1994 Sec. 102(e) Date Feb. 7, 1994 PCT Filed Jun. 17, 1992 PCT Pub. No. WO92/22312 PCT Pub. Date Dec. 23, 1992A tissue treatment composition, especially an adhesive composition comprises (i) fibrin or fibrinogen and (ii) a biodegradable and biocompatible polymer capable of forming a viscous aqueous solution. In addition to glueing, the tissue adhesive composition may be used for slow-release of a drug incorporated into it or for anti-adherence purposes, for wound healing, etc.
Patent AU-774962-B2 (AU)
Title: Stimulation of T cells against self antigens using CTLA-4 blocking agents
Inventor: ALLISON JAMES P
IPC: A61K39/00
Filed: 1999-12-03
Granted: 2004-07-15
Abstract: Stimulation of T cells to respond to self antigens is achieved through a blockade of CTLA-4 signaling. CTLA-4 blocking agents are combined with antigen preparations, either alone or with additional immune response stimulating agents, in costimulation strategies to break immune tolerance and stimulate an enhanced T-cell response against self antigens. This enhanced response is useful for the treatment of non-immunogenic and poorly-immunogenic tumors, as well as other medical conditions requiring selective tissue ablation.
Patent AU-713170-B2 (AU)
Title: Process for the fabrication of electrochemical cell components
Inventor: COOLEY GRAHAM EDWARD
IPC: H01M8/02
Filed: 1997-04-08
Granted: 1999-11-25
Abstract: A process for the fabrication of an electrochemical cell component which comprises an ion exchange membrane joined to a frame member formed from a dissimilar polymeric material, which process comprises the steps of: i) coating the border of at least one face of an ion exchange membrane with a solution in a solvent which is miscible with water of the polymeric material from which the said frame member is made, or of a polymeric material which is compatible with the polymeric frame material; ii) optionally allowing the said coated membrane to stand and/or drying the said coated membrane; iii) placing the coated face of the ion exchange membrane from step (i) or step (ii) in contact with the said frame member; and iv) joining the coated ion-exchange membrane to the said frame member.
Patent AU-694234-B2 (AU)
Title: A catheter system and method for providing cardiopulmonary bypass pump support during heart surgery
Inventor: SWEEZER WILLIAM P
IPC: A61M60/117
Filed: 1995-05-26
Granted: 1998-07-16
Abstract: A catheter system and devices for achieving total cardiopulmonary bypass during heart surgery are provided. The venous perfusion catheter has first and second balloons occluding the inferior and superior vena cava thereby precluding blood flow into the right atrium. An arterial perfusion catheter is inserted, advanced and positioned in the ascending aorta cephalid of the junction of the coronary arteries with the aortic root. A second flexible arterial cannula is mounted in sliding relationship with the first flexible cannula and carries an inflatable balloon adjacent its distal end to provide for occlusion of the ascending aorta. A first flexible cannula has a first lumen and an arterial venting orifice communicating with the first lumen defining a single flow path for the passage of cardioplegia solution to arrest the heart or for the evacuation of blood from the aortic root. A third lumen extends axially through the first flexible arterial cannula and communicates with a multiplicity of openings in the distal tip for suctioning blood from the left ventricle. The second flexible cannula of the arterial perfusion catheter has a first cavity extending axially therethrough that communicates with an opening at its distal tip to permit the passage of blood delivered by the cardiopulmonary bypass pump into arterial circulation. Both the venous and arterial perfusion catheters have a plurality of radially and oppositely spaced steering lumens and a plurality of steering cables fixed to the distal ends to achieve omnidirectional articulation. <IMAGE>
Patent AU-697456-B2 (AU)
Title: Pellets
Inventor: NORLING TOMAS
IPC: A61K9/16
Filed: 1995-06-14
Granted: 1998-10-08
Abstract: A novel drug delivery system, e.g. in the form of a solid dosage form or a liquid formulation based on a pharmaceutical multiple unit in the form of cores such as, e.g., coated cores. The pharmaceutical formulations are based on a novel principle allowing preparation of cores such as, e.g., cores in the form of pellets, i.e. substantially spheric particles which have such a mechanical strength (expressed in terms of friability) that the cores are sufficiently robust to substantially remain intact after having been subjected to coating by standard pharmaceutical procedures well known by a person skilled in the art such as, e.g., a coating process involving a fluidized bed process. A spray-drying process for the preparation of the pharmaceutical formulation is also described.
Patent AU-696520-B2 (AU)
Title: Tolerance-compensating hose clamp
Inventor: OETIKER HANS
IPC: F16L33/025
Filed: 1995-08-01
Granted: 1998-09-10
Abstract: A clamp structure (11) with a clamping band which can be used, for example, to fixedly secure a hose on a nipple and which includes a tightening arrangement (16) for tightening the clamp structure about the object to be fastened by plastic deformation and a tolerance-compensating arrangement in the form of at least one undulation (10); the tolerance-compensating arrangement is thereby separate from the tightening arrangement providing the clamping forces and is so constructed and arranged that the tolerance-compensating arrangement does not affect the holding ability of the tightening arrangement but improves in combination with the tightening arrangement the return spring action of the clamp structure. <MATH>
Patent AU-692279-B2 (AU)
Title: Device for obtaining energy from sunlight with at least one solar collector
Inventor: DAUME JOCHEN
IPC: F24S23/00
Filed: 1995-06-24
Granted: 1998-06-04
Abstract: PCT No. PCT/EP95/02465 Sec. 371 Date Mar. 17, 1997 Sec. 102(e) Date Mar. 17, 1997 PCT Filed Jun. 24, 1995 PCT Pub. No. WO96/00871 PCT Pub. Date Jan. 11, 1996The present invention relates to a device for obtaining heat and/or electrical energy from sunlight with at least one solar collector (2) having an absorber (4) and an energy concentrator (6) surrounding the absorber over its length and at least regions of its periphery and optically concentrating the sunlight on the absorber (4). The energy concentrator (6) has a prism arrangement (12) of transparent material at least at its peripheral region which will be illuminated by the sunlight in accordance with the sun's daily movements, with a plurality of axial adjacent prisms (14) running parallel to the absorber (4) and distributed around the periphery. All the prisms (14) are equal sided in cross section and their apexes (18) are directed towards the absorber (4).
Patent AU-718839-B2 (AU)
Title: Process and installation for in situ testing of the integrity of filtration membranes
Inventor: COTE PIERRE
IPC: B01D65/10
Filed: 1997-05-28
Granted: 2000-04-20
Abstract: A process is described for testing the integrity of liquid filtration membranes without the use of pressurized air. The process includes draining the upstream compartment 3 and filling it with air by venting it to the atmosphere; applying a partial vacuum to the permeate compartment 4 to create a pressure difference across the membrane 2; and measuring the liquid flow out of the permeate chamber that corresponds to air passing through the leak orifices in the membrane. After stabilization of the pressure in the permeate chamber, the resulting constant liquid flow rate out of the permeate chamber is then used to evaluate the integrity of the membrane. An installation for implementing the process is also described and can include a plurality of filtration modules.
Patent AU-662379-B2 (AU)
Title: Aromatic esters of phenylenedialkanoates as inhibitors of human neutrophil elastase
Inventor: OLEKSYSZYN JOZEF
IPC: C07C317/22
Filed: 1992-12-01
Granted: 1995-08-31
Abstract: Compounds of the formula    <IMAGE>  (I)   <IMAGE> (II)  or   <IMAGE> (III)  wherein: R1, R2, R3 and R4, which may be the same or different, are selected from the group consisting of hydrogen, alkyl of 1-6 carbons, cycloalkyl of 3 to 6 carbons, alkenyl of 2-6 carbons, or together represent methylene groups -(CH2)n-where n is a whole number from 1 to 6, provided that R1 and R2 or R3 and R4 are not both hydrogen; R5 and R6, which may be the same or different, are selected from the group consisting of hydrogen, halogen, nitro or -S(O)nR7 where n is 0, 1 or 2 and R7 is an optionally substituted alkyl of 1-12 carbons atoms; and both Ar substituents are optionally substituted heteroaromatic rings or one Ar is such heteroaromatic ring and the other is optionally substituted phenyl, the optional substitution for Ar being halogen, nitro or -S(O)nR7 where n and R7 have the value given above. The compounds are useful as inhibitors of human neutrophil elastase.
Patent AU-778310-B2 (AU)
Title: A universal implant blank for modifying corneal curvature and methods of modifying corneal curvature therewith
Inventor: PEYMAN GHOLAM
IPC: A61F9/007
Filed: 2000-03-01
Granted: 2004-11-25
Abstract: A universally sized blank made of organic or synthetic material that can be placed on an exposed inner surface of a live cornea and ablated with a laser beam to be altered to a particular shape. The blank can be disk-shaped, annularly-shaped with a through opening, or any other suitable shape. A flap-like portion of the live cornea is removed to expose an inner surface of the cornea, and the blank is positioned on the exposed inner surface of the eye. A laser beam is directed onto a portion of the exposed inner surface (e.g., exposed at the opening in the blank), a portion of the blank, or both, based on the type of ametropic condition (i.e., myopia, hyperopia or astigmatism) of the eye needing correction, so that the laser beam ablates those portions of the inner surface and/or blank and thus reshapes the inner surface, the blank, or both. The flap-like portion of the cornea is repositioned over the remaining portion of the blank, so that a remaining portion of the blank and the inner surface influence the shape of the reattached flap-like portion of the cornea and thus modifies the curvature of the cornea.
Patent AU-568718-B2 (AU)
Title: 5 amino or substituted amino 1,2,3-triazoles
Inventor: BOCHIS RICHARD J
IPC: C07D249/04
Filed: 1985-02-01
Granted: 1988-01-07
Abstract: Novel 5-amino or substituted amino 1,2,3-triazoles have the formulaIn whichwhere p is 0,1 or 2; m is 0, 1, 2, 3 or 4; n is 0, 1, 2, 3, 4 or 5; X Is 0, S, SO, SO<sub>2</sub>, CO, CHCN, CH<sub>2</sub> or C=NRe where R<sub>6</sub> is hydrogen, C<sub>1-3</sub> alkyl, hydroxy, C<sub>1-3</sub> alkoxy, amino, C<sub>1-3</sub> alkylamino, di(C<sub>1-3</sub> alkyl)amino or cyano; and each of R<sub>4</sub> and R<sub>5</sub>, independently of the other, is halogen, cyano, trifluoromethyl, C<sub>1-3</sub> alkanoyl, nitro, C<sub>1-3</sub> alkyl, C<sub>1-3</sub> alkoxy, carboxy, alkoxycarbonyl, trifluoromethoxy, acetamido, C<sub>1-3</sub> alkylthio, C<sub>1-3</sub> alkylsulfinyl, C<sub>1-3</sub> alkylsulfonyl, trichlorovinyl, trifluoromethylthio, trifluoromethylsulfinyl or trifluoromethylsulfonyl;R<sub>2</sub> is amino, C<sub>1-3</sub> alkylamino, di(C<sub>1-3</sub> alkyl)amino, acetamido, acetimido, ureido, formamido, formimido or guanidino; andR<sub>3</sub> is carbamoyl, cyano, carbazoyl, amidino or N-hydroxycarbamoyl. Such compounds are anticoccidial and are useful for controlling coccidiosis when administered in minor quantities to animals, in particular to poultry, usually in admixture with their feed.
Patent AU-666563-B2 (AU)
Title: Preparation of 19-nor-vitamin D compounds
Inventor: DELUCA HECTOR F
IPC: C07F7/18
Filed: 1993-08-04
Granted: 1996-02-15
Abstract: A synthesis of 1 alpha -hydroxy-19-nor-vitamin D compounds comprises (a) the construction of a 5,8-diol-6-yne intermediate by joining ring-A and ring-C/D portions of the desired end product via the condensation of an acetylenic derivative containing the C/D-ring portion of the desired end product with a cyclic dihydroxy ketone representing the A-ring of the desired end product; (b) the partial reduction of the 6,7 acetylenic triple bond linkage between the A and C/D ring portions to obtain a 5,8-diol-6-ene intermediate; and (c) the reductive removal of the 5,8-oxygen functions to generate the required 5,7-diene end product from which the desired 7-trans(7E)-isomer is purified directly, or after optional double bond isomerization of the 7-cis(7Z)-isomer employing a novel thiophenol-promoted isomerization step.
Patent AU-733716-B2 (AU)
Title: Polymers containing polysaccharides such as alginates or modified alginates
Inventor: MOONEY DAVID J
IPC: A61K35/34
Filed: 1997-09-19
Granted: 2001-05-24
Abstract: Materials which contain polysaccharide chains, particularly alginate or modified alginate chains. The polysaccharide chains may be included as side chains or auxiliary chains from a backbone polymer chain, which may also be a polysaccharide. Further, the polysaccharide chains may be cross-linked between side chains, auxiliary chains and/or backbone chains. These materials and non-modified or otherwise modified alginate materials are advantageously modified by covalent bonding thereto of a biologically active molecule for cell adhesion or other cellular interaction. Processes for preparation of these alginate materials and methods for using them, particularly for cell transplantation and tissue engineering applications.
Patent AU-767687-B2 (AU)
Title: Toothbrush having controlled head movement
Inventor: MOSKOVICH ROBERT
IPC: A46B9/04
Filed: 2000-04-27
Granted: 2003-11-20
Abstract: The present invention relates to a toothbrush (12) having a handle (18) formed of interlocking opposed S-curved sections, the first (26) being relatively rigid and the second (28) relatively resiliently flexible, the opposed S-curved sections forming a generally elongated figure 8, having a transverse aperture (30, 32) within each segment of the figure 8, such that during brushing the user can manipulate the relatively rigid and resiliently flexible section to position the bristle bearing face (13) of the toothbrush to conform to the arcuate configuration of the dentiture.
Patent AU-725376-B2 (AU)
Title: Peptide-lipid conjugates, liposomes and liposomal drug delivery
Inventor: MEERS PAUL R
IPC: C07K5/08
Filed: 1997-10-15
Granted: 2000-10-12
Abstract: Peptide-lipid conjugates are incorporated into liposomes so as to selectively destabilize the liposomes in the vicinity of target peptidase-secreting cells, and hence, to deliver the liposomes to the vicinity of the target cells, or directly into the cells. The liposomes can thus be used to treat mammals for diseases, disorders or conditions, e.g., tumors, microbial infection and inflammations, characterized by the occurrence of peptidase-secreting cells.
Patent AU-664650-B2 (AU)
Title: An easy to open package
Inventor: FRESCHI CLAUDIO
IPC: B32B27/30
Filed: 1993-10-18
Granted: 1995-11-23
Abstract: An easy to open package, which package is resistent to thermal treatment, is obtained by vacuum skin packaging wherein an article is sealed between a lower and an upper thermoplastic web, the lower web having a first seal layer on its contact surface which first seal layer comprises a mixture of ethylene/vinylacetate, polybutene and polypropylene, the upper web consisting of an irradiated multi-layer film having a second seal layer on its contact surface which second seal layer is selected from the group comprising an ionomer resin and high density polyethylene.
Patent AU-685064-B2 (AU)
Title: Process for separating fullerenes
Inventor: MULLER WOLFGANG
IPC: C01B31/02
Filed: 1993-09-03
Granted: 1998-01-15
Abstract: PCT No. PCT/EP93/02378 Sec. 371 Date May 31, 1995 Sec. 102(e) Date May 31, 1995 PCT Filed Sep. 3, 1993 PCT Pub. No. WO94/06715 PCT Pub. Date Mar. 31, 1994The invention relates to a process for the chromatographic separation of fullerenes using a nonpolar aromatic solvent as eluant. Coke, anthracite and/or graphite are used as support material. The nonpolar solvent is the main constituent of the eluant.
Patent AU-630668-B2 (AU)
Title: Protein labelling using bifunctional hydrazine and hydrazine compounds
Inventor: SCHWARTZ DAVID A
IPC: A61K51/00
Filed: 1990-02-22
Granted: 1992-11-05
Abstract: Bifunctional aromatic compounds which are capable of linking metal ions to biologically useful molecules. The bifunctional compounds are characterized as having a hydrazine or hydrazide group and a protein reactive group. The hydrazine or hydrazide group may be protected as a lower alkyl hydrazone. Conjugates of the bifunctional compounds with macromolecules are also described and labelled macromolecules comprised of the conjugates and metal ions are provided. Additionally, a method is provided for forming a labelled macromolecule by reacting a conjugate with a metal species. The compounds and method of this invention are particularly useful in the fields of biology and medicine for imaging and/or therapy.
Patent AU-573057-B2 (AU)
Title: Polyetherketones
Inventor: STANILAND PHILIP ANTHONY
IPC: C08G65/40
Filed: 1985-12-05
Granted: 1988-05-26
Abstract: Aromatic polyetherketones containing the repeat units:-andin the relative molar proportions I : II of 95 : 5 to 60 : 40, preferably 90 : 10 to 60 : 40. The polymer typically has a melt viscosity of at least 0.06 kN.s.m.<sup>-2</sup> preferably at least 0.1 kN.s.m.<sup>-2</sup>. Preferred polymers are tough. The polymers may be made by condensation of hydroquinone, 4,4'-dihydroxydiphenyl and 4,4,' - difluorobenzophenone in the presence of an alkali metal carbonate or bicarbonate and of an aromatic sulphone solvent, eg diphenylsulphone. Polycondensation is effected at 150-400°C. The polymers are very useful for wire coating.
Patent AU-699623-B2 (AU)
Title: Benzimidazole compounds and their use as modulators of the GABAA receptor complex
Inventor: TEUBER LENE
IPC: C07D405/10
Filed: 1996-04-19
Granted: 1998-12-10
Abstract: PCT No. PCT/EP96/01649 Sec. 371 Date Dec. 23, 1997 Sec. 102(e) Date Dec. 23, 1997 PCT Filed Apr. 19, 1996 PCT Pub. No. WO96/33191 PCT Pub. Date Oct. 24, 1996The present patent application discloses compounds having the formula or a pharmaceutically acceptable salt thereof or an oxide thereof wherein R3 is wherein A, B and D each is CH, or one or two of A, B and D is N and the others are CH; R11 is phenyl, benzimidazolyl, or monocyclic heteroaryl, all of which may be substituted one or more times with substituents selected from alkyl, alkoxy, halogen, CF3, amino, nitro, cyano, acylamino, acyl, phenyl and monocyclic heteroaryl; one of R6 and R7 is hydrogen and the other is -CR'=NOR'', wherein R' and R'' each independently are hydrogen, alkyl, alkenyl, alkynyl or phenyl. The compounds are useful for the treartment of various central nervous system disorders such as epilepsy and other convulsive disorders, anxiety, sleep disorders and memory disorders.
Patent AU-700500-B2 (AU)
Title: Stress-relieving arrangement for carton handles
Inventor: STOUT JAMES T
IPC: B65D5/46
Filed: 1996-05-13
Granted: 1999-01-07
Abstract: A carton for packaging articles includes a generally rectangular top wall having a pair of spaced hand apertures formed therein. The hand apertures are disposed to define therebetween a handle strip for use in lifting the carton. The top wall is provided with a fold line extending from the region of each corner of the top wall toward the handle strip and further with a first severance line extending transversely of each fold line. Each first severance line is interposed between the handle strip and the respective fold line such that each fold line terminates at the respective severance line. This arrangement prevents stress concentration at the region of the handle strip when the carton is lifted.
Patent AU-674385-B2 (AU)
Title: Method for the colorimetric determination of an analyte with a PQQ-dependent dehydrogenase
Inventor: HOENES JOACHIM
IPC: C12Q1/54
Filed: 1994-04-05
Granted: 1996-12-19
Abstract: The invention relates to a method for the colorimetric determination of an analyte by means of enzymatic oxidation with a PQQ-dependent dehydrogenase in the presence of an electron acceptor from the group of electron-rich aromatic nitroso compounds by enzymatic reduction of the nitroso compound to an imino compound and detection of the imino compound by colour formation. The invention furthermore relates to a corresponding composition which contains a PQQ-dependent dehydrogenase, an electron-rich aromatic nitroso compound and, where appropriate, a detection reagent for imino compounds. The invention also relates to nitrosoamino compounds which, on reduction, form coloured quinonediimines, and to the use thereof for the colorimetric enzymatic determination of an analyte.
Patent AU-723119-B2 (AU)
Title: Use of pramipexole in the treatment of restless legs syndrome
Inventor: OERTEL WOLFGANG H
IPC: A61K31/425
Filed: 1998-01-16
Granted: 2000-08-17
Abstract: The present invention provides the use of pramipexole in the treatment of restless legs syndrome.